Literature DB >> 12135328

Two cases of malignant hypertension with reversible diffuse leukoencephalopathy exhibiting a reversible nocturnal blood pressure "riser" pattern.

Kazuo Eguchi1, Kentaro Kasahara, Akinori Nagashima, Tadashi Mor, Takanobu Nii, Kazuo Ibaraki, Kazuomi Kario, Kazuyuki Shimada.   

Abstract

We report two cases of malignant hypertension with reversible diffuse leukoencephalopathy demonstrating a nocturnal blood pressure (BP) rising pattern ("riser" pattern). Case 1 was a 54-year-old man diagnosed with malignant hypertension who presented with diffuse leukoencephalopathy and nocturnal BP rise during the acute phase. These abnormal findings diminished after treatment of hypertension. Case 2 was a 50-year-old woman diagnosed with malignant hypertension in association with leukoencephalopathy, heart failure and acute renal failure. She also presented with a "riser" pattern during the acute phase. In contrast to case 1, the leukoencephalopathy and "riser" pattern in case 2 were not improved even after 1 month of treatment. Following intensive antihypertensive treatment, renal failure was improved in case 1, but renal failure was not improved after 1 month in case 2. In conclusion, a possible explanation of this phenomenon is that a causative volume overload due to renal dysfunction produced the temporal leukoencephalopathy-like brain edema and "riser" pattern in these cases.

Entities:  

Mesh:

Year:  2002        PMID: 12135328     DOI: 10.1291/hypres.25.467

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  2 in total

Review 1.  Management of hypertension emergencies.

Authors:  William J Elliott
Journal:  Curr Hypertens Rep       Date:  2003-12       Impact factor: 5.369

2.  Posterior reversible encephalopathy syndrome in pediatric patients undergoing treatment for hemophagocytic lymphohistiocytosis: clinical outcomes and putative risk factors.

Authors:  Goni Lee; Seung Eun Lee; Kyung-Ha Ryu; Eun Sun Yoo
Journal:  Blood Res       Date:  2013-12-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.